Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ARTVArtiva Biotherapeutics, Inc.

Nasdaq · CIK 0001817241
Filer category<br>Emerging growth company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts176

Identity from submissions API

NameArtiva Biotherapeutics, Inc.
CIK0001817241
TickersARTV
ExchangesNasdaq
Entity typeoperating
Category<br>Emerging growth company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN863614316
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(858) 267-4467
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
5505 MOREHOUSE DRIVE
SAN DIEGO
CA
92121
CA
Mailing address
5505 MOREHOUSE DRIVE
SAN DIEGO
CA
92121
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

240 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-18 4 4 0001193125-26-467092 5035
2026-11-18 4 4 0001193125-26-467089 5077
2026-11-18 4 4 0001193125-26-467085 5019
2026-11-18 4 4 0001193125-26-467073 5038
2026-11-18 4 4 0001193125-26-467071 5073
2026-11-17 8-K 8-K 5.02 0001193125-26-465488 001-42179 261566002 34 166597 1 1
2026-11-09 8-K/A 8-K/A 2.05 0001193125-26-453580 001-42179 261535950 34 179658 1 1
2026-11-09 10-Q 10-Q 0001193125-26-453549 001-42179 261535848 34 11032919 1 1
2026-11-03 4 4 0001193125-26-445335 5077
2026-11-03 4 4 0001193125-26-445331 5018
2026-11-03 4 4 0001193125-26-445314 5038
2026-11-03 4 4 0001193125-26-445312 5072
2026-10-27 8-K 8-K 2.02,2.05,9.01 0001193125-26-432806 001-42179 261487429 34 178182 1 1
2026-10-07 4 4 0001193125-26-416953 5155
2026-10-06 144 xsl144X01/primary_doc.xml 0001950047-26-010072 001-42179 261444321 33 6426
2026-10-06 4 4 0001193125-26-415531 5077
2026-10-06 4 4 0001193125-26-415529 5018
2026-10-06 4 4 0001193125-26-415528 5038
2026-10-06 4 4 0001193125-26-415527 5072
2026-09-15 4 4 0001193125-26-392025 7001
2026-09-14 4 4 0001193125-26-391012 7001
2026-09-14 4 xslF345X06/form4-09142026_100941.xml 0001231919-26-001173 16361
2026-09-14 4 4 0001193125-26-390558 6180
2026-09-14 4 4 0001193125-26-390540 5307
2026-09-14 4 4 0001193125-26-390534 5511
2026-09-14 4 4 0001193125-26-390531 5361
2026-09-14 4 4 0001193125-26-390527 5333
2026-09-14 4 4 0001193125-26-390524 5354
2026-09-11 4 4 0001193125-26-389514 6965
2026-09-11 4 4 0001193125-26-389512 7006
2026-09-11 4 4 0001193125-26-389511 6948
2026-09-11 4 4 0001193125-26-389510 6965
2026-09-11 S-8 S-8 0001193125-26-389428 333-298905 261375307 33 187468 1 1
2026-09-11 8-K 8-K 5.02,5.07,9.01 0001193125-26-389308 001-42179 261374645 34 620361 1 1
2026-09-09 4 4 0001193125-26-386431 5159
2026-09-08 4 xslF345X06/form4-09082026_100904.xml 0001231919-26-001152 16360
2026-09-08 4 4 0001193125-26-385419 5346
2026-09-08 4 4 0001193125-26-385418 5306
2026-09-08 4 4 0001193125-26-385416 5510
2026-09-08 4 4 0001193125-26-385414 5360
2026-09-08 4 4 0001193125-26-385412 5332
2026-09-08 4 4 0001193125-26-385409 5353
2026-09-08 144 xsl144X01/primary_doc.xml 0001950047-26-009217 001-42179 261365480 33 5697
2026-09-04 4 4 0001193125-26-383625 5469
2026-09-04 4 4 0001193125-26-383621 5428
2026-09-04 4 4 0001193125-26-383619 5041
2026-09-04 4 4 0001193125-26-383618 5464
2026-08-31 4 4 0001193125-26-377207 8930
2026-08-27 144 xsl144X01/primary_doc.xml 0001950047-26-008761 001-42179 261330698 33 6211
2026-08-19 4 4 0001193125-26-357383 8528
2026-08-18 144 xsl144X01/primary_doc.xml 0001950047-26-008347 001-42179 261291245 33 5677
2026-08-14 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002667 333-298088 261284609 33 1743
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001231919-26-000930 005-94570 261283129 34 18095
2026-08-10 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001753037-26-000005 005-94570 261260209 34 16446
2026-08-06 S-3 S-3 0001193125-26-338453 333-298088 261250476 33 1648130 1 1
2026-08-06 10-Q 10-Q 0001193125-26-338029 001-42179 261249192 34 10935156 1 1
2026-08-06 8-K 8-K 2.02,9.01 0001193125-26-337986 001-42179 261249025 34 378231 1 1
2026-08-03 ARS ARS 0001193125-26-330570 001-42179 261232943 34 4887655
2026-08-03 DEF 14A DEF 14A 0001193125-26-330563 001-42179 261232899 34 3001272 1 1
2026-07-31 4 xslF345X06/form4-07312026_090755.xml 0001231919-26-000817 19933
2026-07-28 4 xslF345X06/form4-07282026_090756.xml 0001231919-26-000808 17911
2026-07-23 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001346824-26-000203 005-94570 261198260 34 18586
2026-07-23 4 xslF345X06/form4-07242026_010725.xml 0001231919-26-000791 22118
2026-07-23 4/A xslF345X06/form4a-07242026_010759.xml 0001231919-26-000790 15591
2026-07-22 8-K 8-K 8.01 0001193125-26-312560 001-42179 261194485 34 168634 1 1
2026-07-20 4 xslF345X06/form4-07202026_100743.xml 0001231919-26-000774 20012
2026-07-14 4 xslF345X06/form4-07142026_110714.xml 0001231919-26-000764 20013
2026-06-29 4 xslF345X06/form4-06292026_080626.xml 0001231919-26-000711 20013
2026-06-16 4 xslF345X06/form4-06162026_100608.xml 0001231919-26-000656 22118
2026-06-15 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001346824-26-000173 005-94570 261092491 34 17525
2026-06-11 4 xslF345X06/form4-06112026_110625.xml 0001231919-26-000625 21584
2026-05-28 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001931382-26-000009 005-94570 261036965 34 11513
2026-05-28 4 xslF345X06/form4-05282026_080518.xml 0001931382-26-000007 9823
2026-05-19 4 4 0001193125-26-231510 5471
2026-05-19 4 4 0001193125-26-231509 5464
2026-05-19 4 4 0001193125-26-231508 5424
2026-05-19 4 4 0001193125-26-231507 5426
2026-05-19 4 4 0001193125-26-231506 5460
2026-05-19 4 4 0001193125-26-229727 17196
2026-05-19 8-K 8-K 5.02 0001193125-26-229714 001-42179 26995935 34 187204 1 1
2026-05-18 144 xsl144X01/primary_doc.xml 0002028466-26-000003 001-42179 26995549 33 4675
2026-05-18 144 xsl144X01/primary_doc.xml 0001736819-26-000003 001-42179 26995546 33 4674
2026-05-18 144 xsl144X01/primary_doc.xml 0001621152-26-000003 001-42179 26995544 33 4628
2026-05-18 144 xsl144X01/primary_doc.xml 0002065633-26-000003 001-42179 26995538 33 4642
2026-05-18 144 xsl144X01/primary_doc.xml 0001909362-26-000003 001-42179 26995536 33 4674
2026-05-18 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000905148-26-002511 005-94570 26995511 34 36385
2026-05-13 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001346824-26-000129 005-94570 26974849 34 19543
2026-05-13 4 xslF345X06/form4-05132026_090548.xml 0001231919-26-000491 20128
2026-05-08 8-K 8-K 8.01,9.01 0001193125-26-214711 001-42179 26958759 34 622052 1 1
2026-05-08 424B5 424B5 0001193125-26-214706 333-289325 26958725 33 741517
2026-05-08 FWP FWP 0001193125-26-213248 333-289325 26955971 34 83033
2026-05-08 10-Q 10-Q 0001193125-26-213242 001-42179 26955960 34 9398672 1 1
2026-05-08 8-K 8-K 2.02,7.01,8.01,9.01 0001193125-26-213239 001-42179 26955957 34 4369550 1 1
2026-04-30 10-K/A 10-K/A 0001193125-26-197115 001-42179 26924833 34 3533267 1 1
2026-03-10 4 4 0001193125-26-100294 4562
2026-03-10 S-8 S-8 0001193125-26-100245 333-294186 26739847 33 388099 1 1
2026-03-10 10-K 10-K 0001193125-26-100135 001-42179 26739350 34 22771144 1 1
2026-03-10 8-K 8-K 2.02,9.01 0001193125-26-100131 001-42179 26739273 34 337703 1 1
2026-02-24 3 3 0001193125-26-067518 13374
2026-02-24 8-K 8-K 5.02 0001193125-26-067509 001-42179 26672931 34 179765 1 1
2026-02-19 4 4 0001193125-26-060074 5177
2026-02-19 3 3 0001193125-26-060069 13292
2026-02-19 8-K 8-K 5.02 0001193125-26-059716 001-42179 26655674 34 168902 1 1
2026-02-18 4 4 0001193125-26-057674 6207
2026-02-18 4 4 0001193125-26-057672 6201
2026-02-18 4 4 0001193125-26-057669 6163
2026-02-18 4 4 0001193125-26-057668 14878
2026-02-18 4 4 0001193125-26-057667 6192
2025-12-15 4 4 0001193125-25-319696 4626
2025-12-15 144 xsl144X01/primary_doc.xml 0001950047-25-010318 001-42179 251571846 33 6440
2025-12-12 4 4 0001193125-25-317983 26140
2025-12-12 4 4 0001193125-25-317982 21776
2025-12-12 4 4 0001193125-25-317981 23881
2025-12-12 4 4 0001193125-25-317980 27983
2025-12-12 8-K 8-K 5.02 0001193125-25-317784 001-42179 251569177 34 176836 1 1
2025-11-17 4 4 0001193125-25-285009 4732
2025-11-17 4 4 0001193125-25-285008 4725
2025-11-17 4 4 0001193125-25-285006 4688
2025-11-17 4 4 0001193125-25-285005 4660
2025-11-17 4 4 0001193125-25-285004 6652
2025-11-17 144 xsl144X01/primary_doc.xml 0001950047-25-008956 001-42179 251491397 33 5548
2025-11-12 8-K 8-K 7.01,8.01,9.01 0001193125-25-275902 001-42179 251468815 34 243806 1 1
2025-11-12 10-Q 10-Q 0001193125-25-275872 001-42179 251468720 34 11373444 1 1
2025-11-12 8-K 8-K 2.02,9.01 0001193125-25-275867 001-42179 251468687 34 377952 1 1
2025-10-17 4 xslF345X05/form4-10182025_121003.xml 0001909362-25-000004 4800
2025-10-17 144 xsl144X01/primary_doc.xml 0001950047-25-008048 001-42179 251401056 33 5550
2025-08-18 4 xslF345X05/form4-08182025_080810.xml 0001415889-25-022224 8456
2025-08-18 4 xslF345X05/form4-08182025_080807.xml 0001415889-25-022223 6361
2025-08-18 4 xslF345X05/form4-08182025_080805.xml 0001415889-25-022222 6292
2025-08-18 4 xslF345X05/form4-08182025_080803.xml 0001415889-25-022221 6319
2025-08-18 4 xslF345X05/form4-08182025_080801.xml 0001415889-25-022220 6355
2025-08-15 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002641 333-289325 251226183 33 1743
2025-08-15 144 xsl144X01/primary_doc.xml 0001950047-25-005893 001-42179 251224974 33 4819
2025-08-13 CORRESP filename1.htm 0001193125-25-180011 8738
2025-08-11 UPLOAD filename1.pdf 0000000000-25-008421 333-289325 40099
2025-08-06 S-3 S-3 0001193125-25-174570 333-289325 251190670 33 1660505 1 1
2025-08-06 S-8 S-8 0000950170-25-104097 333-289298 251189920 33 347597 1 1
2025-08-06 10-Q 10-Q 0000950170-25-104045 001-42179 251189738 34 10686692 1 1
2025-08-06 8-K 8-K 2.02,9.01 0000950170-25-104028 001-42179 251189683 34 378139 1 1
2025-07-16 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-002480 005-94570 251128454 34 10743
2025-06-26 4 xslF345X05/form4-06262025_080614.xml 0001415889-25-018284 15952
2025-06-26 4 xslF345X05/form4-06262025_040610.xml 0001415889-25-018279 5439
2025-06-26 4 xslF345X05/form4-06262025_040608.xml 0001415889-25-018278 5418
2025-06-26 4 xslF345X05/form4-06262025_040606.xml 0001415889-25-018277 5596
2025-06-26 4 xslF345X05/form4-06262025_040612.xml 0001415889-25-018280 6269
2025-06-26 4 xslF345X05/form4-06262025_040604.xml 0001415889-25-018276 5393
2025-06-26 4 xslF345X05/form4-06262025_040601.xml 0001415889-25-018275 5440
2025-06-25 8-K 8-K 5.02,5.07,9.01 0000950170-25-089942 001-42179 251073623 34 607775 1 1
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000905148-25-001783 005-94570 25954584 34 32011 1 1
2025-05-08 10-Q 10-Q 0000950170-25-066421 001-42179 25923989 34 10197432 1 1
2025-05-08 8-K 8-K 2.02,9.01 0000950170-25-066416 001-42179 25923973 34 358066 1 1
2025-04-29 ARS ARS 0001193125-25-101437 001-42179 25882410 34 8592210
2025-04-29 DEFA14A DEFA14A 0001193125-25-101426 001-42179 25882391 34 492707
2025-04-29 DEF 14A DEF 14A 0001193125-25-101364 001-42179 25882389 34 1516992 1 1
2025-04-25 4 xslF345X05/form4-04252025_090459.xml 0001415889-25-011379 7174
2025-04-25 3 xslF345X02/form3-04252025_090450.xml 0001415889-25-011378 8650
2025-04-23 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-001470 005-94570 25863200 34 10734
2025-03-24 10-K 10-K 0000950170-25-043837 001-42179 25764270 34 28372750 1 1
2025-03-24 8-K 8-K 2.02,9.01 0000950170-25-043828 001-42179 25764225 34 345568 1 1
2025-03-07 4 xslF345X05/form4-03072025_090355.xml 0001415889-25-007431 5281
2025-02-28 4 xslF345X05/form4-02282025_050211.xml 0001415889-25-006037 4811
2025-02-28 4 xslF345X05/form4-02282025_050209.xml 0001415889-25-006036 4784
2025-02-28 4 xslF345X05/form4-02282025_050206.xml 0001415889-25-006035 4804
2025-02-28 4 xslF345X05/form4-02282025_050204.xml 0001415889-25-006034 4740
2025-02-28 4 xslF345X05/form4-02282025_050201.xml 0001415889-25-006033 4767
2025-01-29 4 xslF345X05/form4-01292025_090134.xml 0001415889-25-002273 5434
2025-01-29 3 xslF345X02/form3-01292025_090112.xml 0001415889-25-002272 8500
2025-01-29 8-K 8-K 5.02,9.01 0000950170-25-010481 001-42179 25569383 34 183057 1 1
2024-11-14 SC 13G/A sadavenbioartiva_13ga1.htm 0000905148-24-003191 005-94570 241463884 34 198065
2024-11-12 10-Q 10-Q 0000950170-24-125382 001-42179 241448164 34 10696715 1 1
2024-11-12 8-K 8-K 2.02,9.01 0000950170-24-125359 001-42179 241448085 34 357732 1 1
2024-10-22 4 xslF345X05/form4-10232024_121029.xml 0001415889-24-025537 5457
2024-10-22 3 xslF345X02/form3-10232024_121039.xml 0001415889-24-025536 8407
2024-10-22 8-K 8-K 5.02,9.01 0001193125-24-241059 001-42179 241386467 34 154903 1 1
2024-09-13 4 xslF345X05/form4-09132024_040911.xml 0001415889-24-023364 4812
2024-09-13 4 xslF345X05/form4-09132024_040909.xml 0001415889-24-023363 4785
2024-09-13 4 xslF345X05/form4-09132024_040908.xml 0001415889-24-023362 4805
2024-09-13 4 xslF345X05/form4-09132024_040906.xml 0001415889-24-023361 4740
2024-09-13 4 xslF345X05/form4-09132024_040904.xml 0001415889-24-023360 4767
2024-09-03 SC 13D/A SC 13D/A 0001104659-24-096378 005-94570 241274310 34 64986
2024-08-29 10-Q 10-Q 0001193125-24-209924 001-42179 241263980 34 7370736 1 1
2024-08-29 8-K 8-K 2.02,9.01 0001193125-24-209920 001-42179 241263895 34 229626 1 1
2024-08-01 SC 13G sayw24080101_13g.htm 0000905148-24-002046 005-94570 241168376 34 191746
2024-08-01 SC 13G SC 13G 0001104659-24-084915 005-94570 241166976 34 204954
2024-08-01 SC 13G SC 13G 0001104659-24-084914 005-94570 241166960 34 125245
2024-07-29 SC 13D SC 13D 0001104659-24-083555 005-94570 241152807 34 88135
2024-07-29 SC 13D SC 13D 0001193125-24-187576 005-94570 241152575 34 83550
2024-07-24 4 xslF345X05/form4-07242024_080707.xml 0001415889-24-020047 36163
2024-07-24 4 xslF345X05/form4-07242024_040705.xml 0001415889-24-020035 24484
2024-07-22 4 xslF345X05/form4-07232024_120714.xml 0001415889-24-019908 9449
2024-07-22 4 xslF345X05/form4.xml 0000905148-24-001964 20907
2024-07-22 4 xslF345X05/form4-07232024_120735.xml 0001415889-24-019907 28465
2024-07-22 4 xslF345X05/form4-07232024_120758.xml 0001415889-24-019906 26618
2024-07-22 4 xslF345X05/form4-07232024_120741.xml 0001415889-24-019905 7085
2024-07-22 S-8 S-8 0001193125-24-182301 333-280950 241132393 33 354855
2024-07-22 8-K 8-K 5.03,9.01 0001193125-24-182231 001-42179 241131751 34 47320
2024-07-22 424B4 424B4 0001193125-24-181773 333-280568 241128820 33 7800898
2024-07-19 SEC STAFF LETTER filename1.pdf 9999999997-24-003294 64227
2024-07-18 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-07-18 16:00:00 9999999995-24-002197 333-280568 241125974 33 1750
2024-07-18 3 xslF345X02/form3.xml 0000905148-24-001922 16297
2024-07-18 3 xslF345X02/form3-07192024_120739.xml 0001415889-24-019804 17609
2024-07-18 3 xslF345X02/form3-07192024_120751.xml 0001415889-24-019802 11472
2024-07-18 3 xslF345X02/form3-07192024_120737.xml 0001415889-24-019801 10666
2024-07-18 3 xslF345X02/form3-07192024_120734.xml 0001415889-24-019800 5123
2024-07-18 3 xslF345X02/form3-07192024_120710.xml 0001415889-24-019798 8330
2024-07-18 3 xslF345X02/form3-07192024_120709.xml 0001415889-24-019797 12920
2024-07-18 3 xslF345X02/form3-07192024_120757.xml 0001415889-24-019796 11103
2024-07-18 3 xslF345X02/form3-07192024_120744.xml 0001415889-24-019795 8338
2024-07-18 3 xslF345X02/form3-07192024_120755.xml 0001415889-24-019794 14860
2024-07-18 3 xslF345X02/form3-07192024_120747.xml 0001415889-24-019793 16250
2024-07-18 3 xslF345X02/form3-07192024_120758.xml 0001415889-24-019792 10899
2024-07-18 3 xslF345X02/form3-07192024_120755.xml 0001415889-24-019791 11032
2024-07-18 3 xslF345X02/form3-07192024_120741.xml 0001415889-24-019790 9736
2024-07-18 3 xslF345X02/form3-07192024_120710.xml 0001415889-24-019789 12307
2024-07-18 3 xslF345X02/form3-07192024_120712.xml 0001415889-24-019788 14168
2024-07-18 3 xslF345X02/form3-07192024_120704.xml 0001415889-24-019787 14838
2024-07-18 S-1MEF S-1MEF 0001193125-24-181116 333-280886 241125645 33 64035
2024-07-18 CERT 8A_Cert_ARTV.pdf 0001354457-24-000493 001-42179 241124750 34 753926
2024-07-16 CORRESP filename1.htm 0001193125-24-179664 15668
2024-07-16 CORRESP filename1.htm 0001193125-24-179660 8751
2024-07-16 8-A12B 8-A12B 0001193125-24-179648 001-42179 241119718 34 14102
2024-07-15 S-1/A S-1/A 0001193125-24-178806 333-280568 241115790 33 8590981
2024-07-05 CORRESP filename1.htm 0001193125-24-175667 85887
2024-06-28 CORRESP filename1.htm 0001193125-24-172249 15787
2024-06-28 S-1 S-1 0001193125-24-172230 333-280568 241085585 33 15971911
2024-06-21 UPLOAD filename1.pdf 0000000000-24-007068 377-07214 44250
2024-06-10 DRS/A filename1.htm 0000950123-24-006157 377-07214 241031135 33 6737272
2024-06-07 DRSLTR filename1.htm 0000950123-24-006158 62579
2024-05-31 SEC STAFF LETTER filename1.pdf 9999999997-24-002771 64848
2024-05-30 UPLOAD filename1.pdf 0000000000-24-006248 377-07214 69540
2024-05-03 DRS filename1.htm 0000950123-24-003803 377-07214 24914384 33 14295939
2022-11-01 RW RW 0001193125-22-275086 333-255135 221351608 NE 9566
2022-06-06 S-1/A S-1/A 0001193125-22-168492 333-255135 22999043 33 8008672
2022-03-07 S-1/A S-1/A 0001193125-22-068001 333-255135 22718395 33 7782096
2022-01-21 S-1/A S-1/A 0001193125-22-014926 333-255135 22546875 33 8400305
2021-12-16 S-1/A S-1/A 0001193125-21-358277 333-255135 211495811 33 14185075
2021-04-08 S-1 S-1 0001193125-21-110347 333-255135 21815679 33 9864891
2021-04-05 D xslFormDX01/primary_doc.xml 06b 0001817241-21-000001 021-394686 21804882 33 14930
2021-03-02 DRS filename1.htm 0000950123-21-003225 377-04338 21701142 33 9886477
2020-07-10 D xslFormDX01/primary_doc.xml 06b 0001817241-20-000001 021-370670 201022125 33 12103

Latest XBRL company facts

One latest value per concept from companyfacts (176 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 49.43M 2026-10-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
dei EntityPublicFloat Entity Public Float USD 15.00M 2025-06-30 2025 FY 10-K/A 2026-04-30 0001193125-26-197115
ffd NetFeeAmt NetFeeAmt USD 7,496.63 2026-09-11 S-8 2026-09-11 0001193125-26-389428
ffd TtlFeeAmt TtlFeeAmt USD 7,496.63 2026-09-11 S-8 2026-09-11 0001193125-26-389428
ffd TtlOfferingAmt TtlOfferingAmt USD 54.28M 2026-09-11 S-8 2026-09-11 0001193125-26-389428
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-09-11 S-8 2026-09-11 0001193125-26-389428
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-08-04 S-3 2026-08-06 0001193125-26-338453
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 2.04M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 0 2024-12-31 2024 FY 10-K 2025-03-24 0000950170-25-043837
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 806,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 11.05M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 10.51M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -1.25M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 729.85M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 2.80M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 6.26M 2026-01-01 2026-06-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 7.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap Assets Assets USD 342.98M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap AssetsCurrent Assets, Current USD 326.25M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 1.25M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 204,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 61.23M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 34.25M 2024-06-30 2024 Q2 10-Q 2024-08-29 0001193125-24-209924
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 319.10M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 61.74M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 34.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 15.61M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2024-07-22 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 700.00M 2024-07-22 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 424,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap CommonStockValue Common Stock, Value, Issued USD 5,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -78.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossCurrent Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss, Current USD 1.70M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterestCurrent DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterestCurrent USD 0 2024-06-30 2024 Q2 10-Q 2024-08-29 0001193125-24-209924
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 2.84M 2024-06-30 2024 Q2 10-Q 2024-08-29 0001193125-24-209924
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 3.63M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 875,000 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 91.28M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 16.74M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 3.63M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 54.93M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 3.88M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 11.80M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 87.64M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 2.94M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 688,000 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap Depreciation Depreciation USD 2.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 2.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 25.10M 2023-12-31 2024 FY 10-K 2025-03-24 0000950170-25-043837
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -2.01 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -2.01 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.219 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.014 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.004 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure -0.013 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.038 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 7.04M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 44,000 2025-12-31 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 44,000 2024-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 45,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 164,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 16.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD 83.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -65.37M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0000950170-25-043837
us-gaap IncomeTaxesPaid Income Taxes Paid USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0000950170-25-043837
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 18.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -17.61M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD -30,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 1.19M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 9,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -292,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 1.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 3.22M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 1.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 1.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -26.53M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-24 0000950170-25-043837
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 851,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap IncreaseDecreaseInOtherReceivables Increase (Decrease) in Other Receivables USD -46,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 2.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap InvestmentIncomeNet Investment Income, Net USD 5.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap InvestmentIncomeNetAmortizationOfDiscountAndPremium Investment Income, Net, Amortization of Discount and Premium USD 641,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-29 0001193125-24-209924
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 10.23M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 3.50M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 2.29M 2024-12-31 2024 FY 10-K 2025-03-24 0000950170-25-043837
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 2.28M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 2.28M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 3.60M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 847,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 1.06M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap Liabilities Liabilities USD 22.26M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 342.98M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap LiabilitiesCurrent Liabilities, Current USD 16.41M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap LongTermInvestments Long-term Investments USD 52.97M 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125382
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 283.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -178.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -69.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -77.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 5.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap OperatingExpenses Operating Expenses USD 83.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -83.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap OperatingLeaseCost Operating Lease, Cost USD 2.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 3.04M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125382
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 9.17M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 3.32M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 5.85M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 8.58M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.08 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 1.73M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 1.31M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD 131,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-06 0000950170-25-104045
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -1.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 73,000 2025-12-31 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 73,000 2024-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -8,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 21,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap PaymentsForRepurchaseOfOtherEquity Payments for Repurchase of Other Equity USD 12,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-24 0000950170-25-043837
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 17.30M 2026-05-01 2026-05-31 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 18.39M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-29 0001193125-24-209924
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 241.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 1.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 176.17M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0000950170-25-043837
us-gaap PreferredStockConvertibleSharesIssuable PreferredStockConvertibleSharesIssuable shares 6.16M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2024-07-22 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 7.13M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 30.00M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-29 0001193125-24-209924
us-gaap ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments Proceeds from Sale, Maturity and Collection of Short-term Investments USD 56.35M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0000950170-25-043837
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 64.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 337,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 16.68M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 6.17M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 67.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 504,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -407.89M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 32.92M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-24 0000950170-25-043837
us-gaap RevenueNotFromContractWithCustomer Revenue Not from Contract with Customer USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap Revenues Revenues USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 442,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 282.70M 2026-05-01 2026-05-31 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 6.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum pure 0.01 2024-01-01 2024-12-31 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent pure 0.85 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap ShortTermInvestments Short-term Investments USD 257.87M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 49,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 320.72M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 216.41M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 187,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 282.72M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 210,000 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 270,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap SubleaseIncome Sublease Income USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2024-07-22 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 27.02M 2024-04-29 2024 Q2 10-Q 2024-08-29 0001193125-24-209924
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 6.21M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 1.21M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 24.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-100135
us-gaap VariableLeaseCost Variable Lease, Cost USD 1.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 38.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 38.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453549

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →